Johnson & Johnson stock rose 3.1% after a unit of the consumer healthcare giant refiled for bankruptcy protection as part of a deal that offered to pay $8.9 billion to resolve cancer lawsuits related to its talc-based powders. Johnson & Johnson underlines that the settlement is not an admission of guilt or wrongdoing.
LTL Management – which is a JNJ subsidiary company will pay the money over 25 years to resolve more than 60 thousands claims that the company’s product (baby powder) caused people to develop cancer.
Start investing today or test a free demo
Open account Try demo Download mobile app Download mobile appAnalysts indicate that the above information may have a positive impact on the price of JNJ stock.
According to a JPMorgan analyst $8.9bn committed is in line with their $8-10bn estimate. Similarly analysts from Wells Fargo indicated that it is even slightly higher than expectation of a $10bn settlement.
Markets reacted positively to the above information, the company's shares gained over 3% in the pre-opening phase – trading above $160, which suggests a higher opening during the stock exchange session. The price is back in the consolidation zone. The next move may be crucial for further price development.
Johnson & Johnson (JNJ) stock price, source: xStation 5
This content has been created by XTB S.A. This service is provided by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, entered in the register of entrepreneurs of the National Court Register (Krajowy Rejestr Sądowy) conducted by District Court for the Capital City of Warsaw, XII Commercial Division of the National Court Register under KRS number 0000217580, REGON number 015803782 and Tax Identification Number (NIP) 527-24-43-955, with the fully paid up share capital in the amount of PLN 5.869.181,75. XTB S.A. conducts brokerage activities on the basis of the license granted by Polish Securities and Exchange Commission on 8th November 2005 No. DDM-M-4021-57-1/2005 and is supervised by Polish Supervision Authority.